Publicaciones en colaboración con investigadores/as de Northwestern University (14)

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

2022

  1. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

2019

  1. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models

    Acta neuropathologica communications, Vol. 7, Núm. 1, pp. 64

  2. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Gut roundtable meeting paper: Selected recent advances in hepatocellular carcinoma

    Gut, Vol. 67, Núm. 2, pp. 380-388

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

  2. UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition

    Cell Reports, Vol. 21, Núm. 3, pp. 628-640

2016

  1. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2015

  1. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development

    Nature Medicine, Vol. 21, Núm. 10, pp. 1199-1208

2014

  1. Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation

    PLoS Genetics, Vol. 10, Núm. 9

  2. Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies

    Leukemia

2013

  1. EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

    Cancer Cell, Vol. 23, Núm. 5, pp. 677-692

  2. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer

    Oncogene, Vol. 32, Núm. 23, pp. 2882-2890

2004

  1. Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism

    Biochemical and Biophysical Research Communications, Vol. 322, Núm. 3, pp. 878-886